After a new outbreak of the emerging corona virus, many countries are considering new ways to speed up vaccination campaigns against the epidemic.
In this context, the Indonesian pharmaceutical company, PT Kimia Pharma, will start selling vaccines to the public through private sector hospitals, starting tomorrow, Monday, as the country seeks to accelerate the pace of vaccinations and achieve herd immunity, by the end of this year, according to Bloomberg. news on Sunday.
The company will use doses from a consortium of companies, according to Bambang Hirianto, a spokesperson for PT Bio Pharma, the parent company of Kimia Pharma.
He added, in a press conference today, that apart from commercial entities, private health facilities can now provide doses to individuals, using vaccines, that are not used by the government program.
Hirianto added that “the goal is to expand access to the public, to give them their first dose of the vaccine,” noting that obtaining such doses is an option, for people who are not yet covered by the government program and are not registered with companies that conduct private vaccinations.
Kimya Pharma will sell the vaccines in eight hospitals in several Indonesian cities, including Jakarta, Bandung, Surabaya and Bali in the first phase.